JONES DAY TALKS®: Real Assets Roundup Episode 2: A First Look at Data Centers: The Fourth Utility
LathamTECH in Focus: Tech Deals: The Emerging Focus of FDI Regulators?
LathamTECH in Focus: Navigating National Security: The Impact of FDI Reviews on Tech M&A
Compliance Tip of the Day: Rethinking Corporate AI Governance Through Design Intelligence
Maryland's Sales Tax on IT and Data Services
Sunday Book Review: July 20, 2025, The Best Books on Business Edition
The Briefing: Anthropic, Copyright, and the Fair Use Divide
SkadBytes Podcast | Tech’s Shifting Landscape: Five Trends Shaping the Conversation
No Password Required: From AOL to Award-Winning Cuisine to High-Stakes Hacking
The Authenticity Advantage: How Runbin Dong’s Scale Social AI Helps Small Businesses Shine
#Risk New York Speaker Series – Bridging the Gap: Effective Risk Communication in Compliance with Rob Clark, Jr.
Hsu Untied interview with Brad Waugh, General Counsel at TP-Link
Risk New York Speaker Series: AI Investments and Political Uncertainty with Chris Mason
#Risk New York Speaker Series: Exploring AI Risks in Compliance with Gwen Hassan
Unexpected Paths to IP Law with Dan Young and Colin White
Compliance Needs are Alive and Well: FTC's Recent Enforcement Activity
Innovation in Compliance: The Critical Importance of Mobile Application Security: Insights from Subho Halder
The LathamTECH Podcast — Getting Deals Done: Tackling Antitrust Challenges in Tech M&A
Compliance into the Weeds: Autonomous AI Whistleblowing Misconduct
Daily Compliance News: June 4, 2025, The Climate Disaster Management Edition
2024 was a challenging year for M&A activity in the medical technology (“MedTech”) industry. Although some sectors experienced a rebound in deal volume, MedTech dealmakers were disproportionately affected by a difficult...more
Private equity investors in health care and life sciences must navigate a complex and shifting landscape influenced by regulatory and policy changes and technological advancements. As private equity investments in the health...more
Medtech mergers and acquisitions (M&A) and venture capital (VC) showed signs of life in 2024, contributing to an overall optimistic outlook for the sector this year despite lingering headwinds. Strategic investments are...more